During our medical school rotations, we are taught that accessing the cerebral cortex requires an almost sacred respect for the protective layers surrounding it. Historically, implanting any Brain-Computer Interface (BCI) meant that opening or resecting a portion of the dura mater (durotomy) was considered an unavoidable step. However, neuroengineering has just challenged this surgical dogma.
In May 2026, Neuralink, in collaboration with Dr. Andres Lozano at the University Health Network (UHN) in Toronto, Canada, performed its very first human transdural surgery. The breakthrough? Leaving the dura mater completely intact and inserting the microelectrode threads directly through it.
For medical students and healthcare professionals, this milestone is more than just a feat of engineering; it is a drastic redefinition of patient safety and perioperative morbidity in functional neurosurgery.
The clinical toll of opening the dura mater
Anyone who has scrubbed into a neurosurgery case knows that manipulating the dura mater carries significant risks well-documented in medical literature. The dural membrane is thick, densely collagenous, and serves as the central nervous system’s primary mechanical and biological barrier. When a duractomy is performed, it opens the door to major complications:
- CSF Leaks: Achieving a completely airtight dural closure is notoriously difficult, risking cerebrospinal fluid leaks.
- Elevated Infection Risks: Exposing the subarachnoid space increases patient vulnerability to meningitis or subdural empyemas.
- The Glial Response: Macroscopic surgical trauma triggers reactive astrocytic proliferation (gliosis). Over time, this glial scar tissue encapsulates microelectrodes, degrading electrical signal quality.
By bypassing this step entirely, Neuralink has eliminated the single biggest biological bottleneck of the procedure.
Overcoming mechanical resistance: redesigning the needle
The human dura mater has a tough, leathery consistency. During initial engineering trials, ultra-thin robotic needles either deflected or caused excessive mechanical compression on the underlying cortex before managing to puncture the membrane.
The bioengineering team’s solution was purely mechanical: they slightly increased the diameter of the insertion needle. This strategic adjustment provided the structural rigidity required for a clean, perpendicular, micron-level puncture, allowing the electrode threads to pass through the dura without tearing the surrounding tissue.
Navigating blind: the role of real-time bioimaging
Leaving the dura mater intact means the surgeon loses direct macroscopic visualization of the cortex. How does the robot ensure it won’t puncture a major blood vessel or miscalculate implant depth? This is where the surgical robot’s integrated bioimaging systems come into play:
- Infrared Indocyanine Green (ICG) Angiography: The patient receives an intravenous contrast dye. The robot emits infrared light, causing the cortical blood vessels to glow and become perfectly visible through the opaque dura mater. The navigation algorithm maps the vascular bed in fractions of a second and charts the needle’s trajectory, avoiding hemorrhagic iatrogenesis.
- Optical Coherence Tomography (OCT): A living brain is never static; it constantly pulses with the cardiovascular system and respiratory mechanics. Using laser interferometry, OCT reconstructs a 3D volume in real time. This allows the system to actively measure the exact dynamic distance between the dural surface, the subarachnoid space (SAS), and the cortex, ensuring threads are inserted to the correct histological depth.
The big picture: automation and outpatient scalability
The most fascinating concept highlighted by the medical team regarding this transdural procedure is the strategy of “deleting steps.” In surgical automation, the fewer complex steps a robot needs to perform (such as cutting, retracting, and suturing biological membranes), the safer and faster the intervention becomes.
Eliminating the duractomy substantially reduces operating room time and moves BCIs closer to an outpatient procedure profile. For medicine, this signals a future where restorative neurological therapies, vital for patients with severe spinal cord injuries or neurodegenerative diseases, can finally be scaled safely and accessibility at a population level.
About Educar Med
Educar Med isn’t just about passing tests; it’s about rejecting clinical mediocrity. We are a community dedicated to training the new generation of physicians who think, examine with precision, and transform lives.
Keep raising your clinical standards. Follow Educar Med on social media: